PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
07-Sep-2022 Marinus Pharmaceuticals to Present at Upcoming Investor Conferences Businesswire
07-Sep-2022 Pyramid Biosciences Names Biren Amin as Chief Financial and Strategy Officer Businesswire
07-Sep-2022 Ian Read named Chairman of the Board of Areteia Therapeutics Businesswire
07-Sep-2022 GRO Biosciences Announces Addition of Nicole Paulk, PhD, to Scientific Advisory Board Businesswire
07-Sep-2022 Glaukos Announces Positive Topline Outcomes for Both Phase 3 Pivotal Trials of iDose TR, Achieving Primary Efficacy Endpoints and Demonstrating Favorable Tolerability and Safety Profiles Businesswire
07-Sep-2022 ProBioGen and City of Hope Announce Commercial License Agreement to Use AGE1.CR.pIX® Vaccine Manufacturing Platform for Cytomegalovirus (CMV) Vaccine B3C newswire
07-Sep-2022 Otolith Labs Announces $20 Million Series A Financing by Morningside Ventures Businesswire
07-Sep-2022 Precision BioSciences to Participate in Upcoming H.C. Wainwright 24th Annual Global Investment Conference Businesswire
07-Sep-2022 GlycoMimetics to Participate in Upcoming H.C. Wainwright 24th Annual Global Investment Conference Businesswire
07-Sep-2022 Seres Therapeutics Announces Completion of Rolling BLA Submission to FDA for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection Businesswire
07-Sep-2022 Salubris Biotherapeutics Announces Updated Phase 1b Data Demonstrating that JK07, the First Investigational Antibody Fusion Protein for Heart Failure, Resulted in Clinically Meaningful Improvements in Ejection Fraction Businesswire
07-Sep-2022 Aura Biosciences to Present Phase 2 Safety Data Evaluating Suprachoroidal Administration of Belzupacap Sarotalocan (AU-011) in Patients with Choroidal Melanoma at the ESMO 2022 Congress Businesswire
07-Sep-2022 Bicycle Therapeutics Announces BT5528 Phase I Dose Escalation Results in Patients with Advanced Solid Tumors Businesswire
07-Sep-2022 PTC Therapeutics’ 2022 STRIVE Awards Program Funds Initiatives Supporting the Duchenne Patient Community PTC
07-Sep-2022 KITE’S CAR T-CELL THERAPY TECARTUS® (BREXUCABTAGENE AUTOLEUCEL) GRANTED EUROPEAN MARKETING AUTHORISATION FOR THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA (r/r ALL) KITES
07-Sep-2022 Ernst and Young Selects Josh Eckman, CEO of Carterra, as 2022 Entrepreneur of the Year® Mountain West Award Winner Ernst and Young
07-Sep-2022 Cegedim Healthcare Solutions wins its first Direct Award in Scotland, to supply its new generation GP IT solution cegedim
07-Sep-2022 Evox Therapeutics Expands its Exosome Manufacturing Patent Portfolio Evox
07-Sep-2022 VanDeMark Chemical Announces Investment From SK Capital in Partnership with Comvest Partners Businesswire
07-Sep-2022 Orbital Therapeutics Launches to Advance New Frontiers of Science with the Next Generation of Innovative RNA Medicines Businesswire